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Budd-Chiari syndrome may be defined as an heterogeneous group of vascular disorders characterized by 
obstruction of hepatic venous return to the level of hepatic venules, supra-hepatic veins, inferior vena cava or 
right atrium. The main cause of this syndrome is represented by myeloproliferative diseases, and, in 
particular, by polycythaemia vera. The latter may cause multiple splanchnic thrombosis, including portal 
vein thrombosis, particularly important, especially for its clinical outcomes (ascites, collateral vessels 
genesis, etc.). Here we reported two cases of a Budd-Chiari syndrome induced by polycythaemia vera 
characterized by an abnormal clinical onset, both as regards subject's age (29 and 39 years old, respectively) 
and set of symptoms, signs and laboratory data. After a complete clinical, instrumental and genetic 
diagnosis, the patients were treated with combined therapy, using acetylsalicylic acid and hydroxyurea. The 
therapy proved successful and patients are still in follow-up in our Institution. Polycythaemia vera should be 
suspected in patient affected with portal vein thrombosis and Budd-Chiari syndrome even if its clinical onset 
might be unusual. A correct and early diagnosis should be kept to start appropriate therapy as soon as 
possible and to prevent patients from useless diagnostic and therapeutic treatments. 
 
